One of the more popular ideas floating around on Wall Street, Hims & Hers Health Inc (NYSE:HIMS) has largely benefited from the general ascendancy of the telehealth business model, along with strong demand for weight-loss treatments. However, it's also a speculative investment, with the wellness platform facing a crowded digital health industry along with a steep valuation. Still, the quantitative picture for HIMS stock appears intriguing.
To be upfront, the idea of Hims & Hers Health entered my inbox earlier this morning as a spam-like ticker recommendation. Initially, my instinct was to ignore it like every other piece of junk mail that I receive on the daily — and for good reason. While HIMS stock is up more than 68% on a year-to-date basis, it's been down roughly 26% in the trailing month.
